scispace - formally typeset
S

Syed H.E. Zaidi

Researcher at Ontario Institute for Cancer Research

Publications -  57
Citations -  2354

Syed H.E. Zaidi is an academic researcher from Ontario Institute for Cancer Research. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 22, co-authored 46 publications receiving 1792 citations. Previous affiliations of Syed H.E. Zaidi include University Health Network & University of Toronto.

Papers
More filters
Journal ArticleDOI

Genetic Mechanisms of Immune Evasion in Colorectal Cancer

TL;DR: This large-scale genomic analysis of colorectal cancer demonstrates that MSI-high cases frequently undergo an immunoediting process that provides them with genetic events allowing immune escape despite high mutational load and frequent lymphocytic infiltration and, furthermore, that coloreCTal cancer tumors have genetic and methylation events associated with activated WNT signaling and T-cell exclusion.
Journal ArticleDOI

Discovery of common and rare genetic risk variants for colorectal cancer

Jeroen R. Huyghe, +224 more
- 01 Jan 2019 - 
TL;DR: Genome-wide association analyses based on whole-genome sequencing and imputation identify 40 new risk variants for colorectal cancer, including a strongly protective low-frequency variant at CHD1 and loci implicating signaling and immune function in disease etiology.
Journal ArticleDOI

Overexpression of the Serine Elastase Inhibitor Elafin Protects Transgenic Mice From Hypoxic Pulmonary Hypertension

TL;DR: Modulation of the severity of chronic hypoxia-induced pulmonary vascular disease could be a function of endogenously expressed serine elastase inhibitors.
Journal ArticleDOI

Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (β4GalT-7)

TL;DR: The reduced β4GalT-7 activity resulting in defective glycosylation of decorin and biglycan may be responsible for the complex molecular pathology in β4 galactosyltransferase deficient EDS patients, given the role of these proteoglycans in bone formation, collagen fibrillogenesis, and skeletal muscle development.